We are disappointed that the FDA did not approve our application. While we believe that a delay is not justified, we will use the opportunity presented by the FDA proceedings to continue to press for approval of Plan B as an OTC/Rx Product.
Bruce L. Downey
This decision could have been reached much earlier, and we could have been well into the proceeding that they're now just starting.
decision starting
opportunity plan press delay approval
You must log in to post a comment.
There are no comments yet.